Dr. Russell Buhr Receives 2024 Solovy Award for Advancement in COPD

June 6, 2024 – CHICAGO – Respiratory Health Association (RHA) is proud to present the 2024 Solovy Award for Advancement in COPD to Russell Buhr, MD, PhD, FACP, ATSF. The $25,000 award will allow Dr. Buhr to further his ongoing COPD research to close the gap between scientific advances at the bench and implementing them at the bedside.

Dr. Buhr’s medical research has focused on better understanding the biology and natural course of COPD, particularly in the early stages, with the goal of discovering better targets for treatment. His PhD research centers on understanding how Medicare policies that penalize hospitals for readmissions following COPD exacerbations affect patient outcomes.

“It’s not only our patients that suffer from the terrible burdens of COPD, but also their families, who see their loved one robbed of their independence by shortness of breath, fatigue, and oftentimes stigma associated with COPD’s connection to smoking. It may sound like something that is simple to achieve, but we are still a long way from understanding how to consistently get the right interventions to the right patients at the right time to improve their health and their quality of life,” said Dr. Buhr.  “I am delighted and humbled to be recognized and supported by the Solovy Award for my team’s ongoing work in this area.”

The Solovy Award for Advancement in COPD recognizes innovation and continued progress in the prevention, treatment, and cure for COPD. The award was established by Kathleen Hart Solovy in memory of her husband, Jerold S. Solovy, and is funded by the Kathleen Hart Solovy and Jerold S. Solovy Endowment for COPD. Jerry lived for many years with COPD, and both he and Kathleen recognized the health burden.

“We are excited to recognize Dr. Buhr for his work on behalf of COPD patients,” said Joel Africk, RHA President and CEO. “COPD affects nearly 16 million Americans and has claimed too many of our family members, friends, and colleagues.”

Each year, Respiratory Health Association awards early-stage research grants to promising projects covering lung diseases such as lung cancer, idiopathic pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD). Learn more about RHA’s research program and funding opportunities at RespHealth.org/Research.


About Respiratory Health Association

RHA has been a local public health leader in Chicago since 1906. RHA works to prevent lung disease, promote clean air, and help people live better through education, research, and policy change. To learn more, visit RespHealth.org.